Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$185.15M-14.0% | -$162.45M-8.3% | -$149.96M-5.4% | -$142.3M-10.4% | -$128.89M+0.4% | ||
| $481K-1.8% | $490K+16.9% | $419K-11.0% | $471K+8.8% | $433K+10.2% | ||
| $23.36M+32.8% | $17.59M-10.5% | $19.64M-6.5% | $21.02M-4.7% | $22.05M-2.4% | ||
| —— | —— | —— | —— | —— | ||
| $3.72M-35.5% | $5.77M+79.5% | $3.21M-4.4% | $3.36M+128% | $1.47M+243% | ||
| $23.54M+114% | $10.98M+14.6% | $9.58M+0.9% | $9.5M+2,554% | $358K-96.8% | ||
| $1.19M+1.2% | $1.18M+1.2% | $1.16M+1.0% | $1.15M+0.1% | $1.15M-0.1% | ||
| -$1.25M-0.3% | -$1.24M-0.6% | -$1.24M-0.6% | -$1.23M-1.5% | -$1.21M-4.2% | ||
| —— | -$6.29M+7.0% | -$6.76M+6.5% | -$7.23M+6.1% | -$7.7M+5.8% | ||
| -$148.72M-1.4% | -$146.72M-8.9% | -$134.67M-5.9% | -$127.16M-1.9% | -$124.83M-19.6% | ||
| —— | —— | —— | —— | -$118.47M-26.7% | ||
| $16.59M+97.7% | $8.39M+662% | $1.1M-4.4% | $1.15M+16.7% | $987K-40.9% | ||
| —— | —— | —— | —— | —— | ||
| $256.78M+21.5% | $211.3M-12.7% | $242.05M0.0% | $242.1M-7.0% | $260.22M-3.2% | ||
| —— | —— | —— | —— | $16.92M-76.1% | ||
| —— | -$6.29M+7.0% | -$6.76M+6.5% | -$7.23M+6.1% | -$7.7M+5.8% | ||
| -$1.25M-0.3% | -$1.24M-0.6% | -$1.24M-0.6% | -$1.23M-1.5% | -$1.21M-4.2% | ||
| $23.54M+114% | $10.98M+14.6% | $9.58M+0.9% | $9.5M+2,554% | $358K-96.8% | ||
| $5.28M-14.1% | $6.15M+2.1% | $6.02M+165% | $2.27M-11.9% | $2.58M-12.8% | ||
| $3.72M-35.5% | $5.77M+79.5% | $3.21M-4.4% | $3.36M+128% | $1.47M+243% | ||
| —— | —— | $6.76M-9.1% | $7.44M-6.0% | $7.92M-3.1% | ||
| $1.19M+1.2% | $1.18M+1.2% | $1.16M+1.0% | $1.15M+0.1% | $1.15M-0.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $205.39M— | —— | —— | —— | ||
| -$1.25M-0.3% | -$1.24M-0.6% | -$1.24M-0.6% | -$1.23M-1.5% | -$1.21M-4.2% | ||
| —— | -$95K+38.9% | -$155.5K+28.0% | -$216K+21.9% | -$276.5K+18.0% | ||
| —— | $177K-44.6% | $319.75K-30.9% | $462.5K-23.6% | $605.25K-19.1% | ||
| —— | $578K-71.9% | $2.06M-41.8% | $3.54M-29.5% | $5.02M-22.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Olema Pharmaceuticals, Inc. generate?
- Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
- Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.